Suppr超能文献

婴儿中乳酸奈瑟菌的遗传多样性及携带动态

Genetic diversity and carriage dynamics of Neisseria lactamica in infants.

作者信息

Bennett Julia S, Griffiths David T, McCarthy Noel D, Sleeman Karen L, Jolley Keith A, Crook Derrick W, Maiden Martin C J

机构信息

The Peter Medawar Building for Pathogen Research and Department of Zoology, University of Oxford, South Parks Rd., Oxford OX1 3SY, United Kingdom.

出版信息

Infect Immun. 2005 Apr;73(4):2424-32. doi: 10.1128/IAI.73.4.2424-2432.2005.

Abstract

Neisseria lactamica, a harmless human commensal found predominantly in the upper respiratory tracts of infants, is closely related to Neisseria meningitidis, a pathogen of global significance. Colonization with N. lactamica may be responsible for the increase in immunity to meningococcal disease that occurs during childhood, when rates of meningococcal carriage are low. This observation has led to the suggestion that N. lactamica whole cells or components are potential constituents of novel meningococcal vaccines. However, the dynamics of carriage and population diversity of N. lactamica in children are poorly understood, presenting difficulties for the choice of representative isolates for use in vaccine development. This problem was addressed by the multilocus sequence typing of N. lactamica isolates from two longitudinal studies of bacterial carriage in infants. The studies comprised 100 and 216 subjects, with N. lactamica carriage monitored from age 4 weeks until age 96 weeks and from age 2 weeks until age 24 weeks, respectively. The maximum observed carriage rate was 44% at 56 weeks of age, with isolates obtained on multiple visits for the majority (54 of 75, 72%) of carriers. The N. lactamica isolates were genetically diverse, with 69 distinct genotypes recovered from the 75 infants. Carriage was generally long-lived, with an average rate of loss of under 1% per week during the 28 weeks following acquisition. Only 11 of the 75 infants carried more than one genotypically unique isolate during the course of the study. Some participants shared identical isolates with siblings, but none shared identical isolates with their parents. These findings have implications for the design of vaccines based on this organism.

摘要

乳酸奈瑟菌是一种主要存在于婴儿上呼吸道的无害人体共生菌,与具有全球重要意义的病原体脑膜炎奈瑟菌密切相关。乳酸奈瑟菌的定植可能是儿童期对脑膜炎球菌病免疫力增强的原因,而儿童期脑膜炎球菌携带率较低。这一观察结果表明,乳酸奈瑟菌全细胞或其成分可能是新型脑膜炎球菌疫苗的潜在成分。然而,人们对儿童中乳酸奈瑟菌的携带动态和种群多样性了解甚少,这给用于疫苗开发的代表性菌株的选择带来了困难。通过对两项婴儿细菌携带纵向研究中分离出的乳酸奈瑟菌进行多位点序列分型,解决了这个问题。这两项研究分别包括100名和216名受试者,乳酸奈瑟菌携带情况分别从4周龄监测至96周龄以及从2周龄监测至24周龄。观察到的最高携带率在56周龄时为44%,大多数携带者(75名中的54名,72%)在多次访视时获得了分离株。乳酸奈瑟菌分离株具有遗传多样性,从75名婴儿中分离出了69种不同的基因型。携带通常具有长期性,在获得后的28周内平均每周丢失率低于1%。在研究过程中,75名婴儿中只有11名携带了一种以上基因型独特的分离株。一些参与者与兄弟姐妹共享相同的分离株,但没有人与他们的父母共享相同的分离株。这些发现对基于该生物体的疫苗设计具有启示意义。

相似文献

1
Genetic diversity and carriage dynamics of Neisseria lactamica in infants.
Infect Immun. 2005 Apr;73(4):2424-32. doi: 10.1128/IAI.73.4.2424-2432.2005.
3
Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?
Expert Rev Vaccines. 2005 Jun;4(3):373-9. doi: 10.1586/14760584.4.3.373.
4
Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization.
J Clin Microbiol. 2012 Dec;50(12):4020-7. doi: 10.1128/JCM.01717-12. Epub 2012 Oct 3.
5
Epidemiology and molecular characterization of Neisseria lactamica carried in 11-19 years old students in Salvador, Brazil.
Int J Med Microbiol. 2018 Jun;308(4):454-458. doi: 10.1016/j.ijmm.2018.03.007. Epub 2018 Mar 27.
6
Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece.
FEMS Immunol Med Microbiol. 2003 Oct 24;39(1):23-9. doi: 10.1016/S0928-8244(03)00174-3.
8
The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Vaccine. 2005 Mar 18;23(17-18):2210-3. doi: 10.1016/j.vaccine.2005.01.055.
10
A common gene pool for the Neisseria FetA antigen.
Int J Med Microbiol. 2009 Feb;299(2):133-9. doi: 10.1016/j.ijmm.2008.06.010. Epub 2008 Aug 20.

引用本文的文献

1
Optimization of methods for isolation and purification of outer membrane vesicles (OMVs) from Neisseria lactamica.
Appl Microbiol Biotechnol. 2025 Apr 7;109(1):82. doi: 10.1007/s00253-025-13460-y.
2
OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans.
NPJ Vaccines. 2023 Apr 12;8(1):54. doi: 10.1038/s41541-023-00651-9.
3
5
Meningococcal Quinolone Resistance Originated from Several Commensal Species.
Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.01494-19.
6
Genomic characterization of novel Neisseria species.
Sci Rep. 2019 Sep 24;9(1):13742. doi: 10.1038/s41598-019-50203-2.
9
Gonorrhea - an evolving disease of the new millennium.
Microb Cell. 2016 Sep 5;3(9):371-389. doi: 10.15698/mic2016.09.524.

本文引用的文献

1
mlstdbNet - distributed multi-locus sequence typing (MLST) databases.
BMC Bioinformatics. 2004 Jul 1;5:86. doi: 10.1186/1471-2105-5-86.
3
Multi-locus sequence typing: a tool for global epidemiology.
Trends Microbiol. 2003 Oct;11(10):479-87. doi: 10.1016/j.tim.2003.08.006.
4
Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece.
FEMS Immunol Med Microbiol. 2003 Oct 24;39(1):23-9. doi: 10.1016/S0928-8244(03)00174-3.
6
Neisseria lactamica protects against experimental meningococcal infection.
Infect Immun. 2002 Jul;70(7):3621-6. doi: 10.1128/IAI.70.7.3621-3626.2002.
7
Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology.
Int J Syst Evol Microbiol. 2002 May;52(Pt 3):1043-1047. doi: 10.1099/00207713-52-3-1043.
8
MEGA2: molecular evolutionary genetics analysis software.
Bioinformatics. 2001 Dec;17(12):1244-5. doi: 10.1093/bioinformatics/17.12.1244.
9
Sequence type analysis and recombinational tests (START).
Bioinformatics. 2001 Dec;17(12):1230-1. doi: 10.1093/bioinformatics/17.12.1230.
10
Genetic diversity of Neisseria lactamica strains from epidemiologically defined carriers.
J Clin Microbiol. 2001 May;39(5):1710-5. doi: 10.1128/JCM.39.5.1710-1715.2001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验